Skip to main content

This job has expired

You will need to login before you can apply for a job.

Director, Digital Medicine, Clinical Sciences

Regeneron Pharmaceuticals, Inc.
Tarrytown, New York
Start date
Apr 5, 2024

View more

Job Details

As a Director, Digital Medicine at Regeneron, reporting to the VP, Clinical Sciences, you will play the lead role in driving digital biomarker strategy for clinical development programs. The mission is to transform the landscape of drug trial outcome measures by directly quantifying patient function in a real-world setting. Contribute to the digital biomarker strategies to support the Regeneron clinical development pipeline. Progress digital biomarker development projects through concept identification, device landscape scoping, device selection and endpoint development strategy. Design and conduct technical and clinical validation studies in patients. The long-term objective will be to qualify digital sensor parameters into digital endpoints to inform internal Regeneron decision making in proof-of-concept therapeutic trials.

As a Director, a typical day may include the following:

  • Lead the development and implementation of a program-level digital medicine strategy aligned with the indications and potential clinical effects of Regenerons pipeline of innovative medicines

  • Ability to conceptualize the relationship between patient function and symptoms

  • Contribute to Regenerons mission to advance the field of digital medicine and identify new opportunities for innovation related to advancements; Maintaining an active collaborative network with external leaders in the field

  • Collaborate with cross-functional team members in Regeneron; Clinical Therapeutic Area leaders, Patient Innovation Laboratory & Operations leaders, Biostatistics, Quantitative Science leaders across Global Development and Regeneron Genetics Center, Patient-Centered Outcomes Research, Digital Technology, Engineering Services, Precision Medicine, and Imaging

  • Evaluate digital sensor technologies potentially capable of measuring relevant patient function across a broad disease portfolio; Evaluate existing device verification and validation data for selected sensor technologies, perform gap analyses and studies to further validate digital biomarkers in specified patient populations

  • Lead in the development and execution of studies to generate digital biomarkers from sensor data and implement them into drug development programs, developing them into trial endpoints

  • Seek input from physician-scientist disease area experts, provide context to quantitative scientists developing advanced statistical and computational methods to analyze large- and mid-scale digital biomarker datasets

  • Collaborate with bioinformatics and artificial intelligence/machine learning data science teams in development of novel methods for sensor data exploration and biomarker discovery

This role may be for you if:

  • Excellent communication skills, both written and verbal, with the ability to optimally communicate complex scientific concepts to diverse, cross-functional collaborators and senior management

  • Passionate about revolutionizing healthcare and want to transform Regenerons approach to drug development, we invite you to apply for the opportunity to join our dynamic team

To be considered for this role, you must have a Ph.D + 8 years of experience in a relevant scientific field (e.g., translational research, biomedical engineering, bioinformatics, biological science) or M.D. with both board certification and a track record of digital medicine research. 3 + years of experience in digital biomarker science (in a related field such as molecular biomarker or imaging sciences) within the pharmaceutical, biotechnology industry, or academia (post-doctoral/clinical fellowship level, 5+ years) in the digital biomarker field. Additionally, we need an individual with a proven publication record. We are seeking a strong understanding of regulatory requirements and industry standards related to digital biomarkers and devices, qualification of digital endpoints and clinical research. We require an understanding of clinical disease functional conceptualization, digital health technologies for ecological data collection, quantitative sciences, and the process of biomarker development. Additionally, fit-for-purpose qualification depending on context-of-use, including specific regulatory requirements (including medical devices and endpoint validation).

Does this sound like you? Apply now to take your first steps toward living the Regeneron Way! We have an inclusive and diverse culture that provides comprehensive benefits including health and wellness programs, fitness centers and equity awards, annual bonuses, and paid time off for eligible employees at all levels!

Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, nationality, national or ethnic origin, civil status, age, citizenship status, membership of the Traveler community, sexual orientation, disability, genetic information, familial status, marital or registered civil partnership status, pregnancy or parental status, gender identity, gender reassignment, military or veteran status, or any other protected characteristic in accordance with applicable laws and regulations. We will ensure that individuals with disabilities are provided reasonable accommodations to participate in the job application process. Please contact us to discuss any accommodations you think you may need.

The salary ranges provided are shown in accordance with U.S. law and apply to U.S. based positions, where the hired candidate will be located in the U.S. If you are outside the U.S, please speak with your recruiter about salaries and benefits in your location.

Salary Range (annually)

$198,000.00 - $330,000.00


Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.

Stock Symbol: REGN

Stock Exchange: NASDAQ

FacebookTwitterInstagramYouTube Logo

Company info
Corporate Headquarters
777 Old Saw Mill River Road
New York

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert